MANAGING PARTNER
David Maris
David Maris has more than 25+ years of Wall Street experience in healthcare and finance in a variety of roles, most notably as a six-time #1 Institutional Investor ranked healthcare equity research analyst, but also as a portfolio manager for a leading hedge fund, and a trusted and collaborative advisor to management teams and boards.
Maris is known for his thorough research and in-depth analysis of healthcare companies, their financials, and strategies as well as his keen understanding of the regulatory environment in the healthcare industry.
“He has been recognized for his accuracy and foresight in predicting the performance of healthcare companies and their products. His viewpoints are often sought after by investors and industry stakeholders. ”
David has been featured for his views on various healthcare-related topics in prominent media outlets including CNBC, The Wall Street Journal, The New York Times, STAT, Bloomberg, CBS Evening News, NBC Nightly News, Good Morning America, Smart Money (“Five Honest Analysts”), The Financial Times, The Los Angeles Times, and The Economist.
Mr. Maris’ research has also been the subject of several business school cases, including a Harvard Business School case taught each year at Harvard Business School for the past ten years.
David is an experienced public company board member having served on the board of directors of Cosmo Pharmaceuticals, and Amphastar Pharmaceuticals. He also serves as an advisor to Iacta Pharmaceuticals (private).
He has expertise as a keynote speaker for numerous leading and emerging drug company management teams and boards, as well as several leading industry organizations.
Memberships include the American Finance Association and National Association of Corporate Directors.